• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.69% Nasdaq Up0.44%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    2.11 Down 0.44(17.25%) Jul 29, 4:00PM EDT
    |After Hours : 2.05 Down 0.06 (2.84%) Jul 29, 7:08PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2014Jun 30, 2013Jun 30, 2012
    Total Revenue 9,042   4,962   32,734  
    Cost of Revenue1,528  393  427  
    Gross Profit 7,514   4,569   32,307  
    Operating Expenses
    Research Development33,680  28,381  24,256  
    Selling General and Administrative9,414  6,981  6,609  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (35,580) (30,792) 1,443  
    Income from Continuing Operations
    Total Other Income/Expenses Net57  19,350  32  
    Earnings Before Interest And Taxes(35,523)(11,442)1,475  
    Interest Expense -   -   -  
    Income Before Tax(35,523)(11,442)1,475  
    Income Tax Expense8  44  210  
    Minority Interest105  105  114  
    Net Income From Continuing Ops(35,426)(11,382)1,378  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (35,426) (11,382) 1,378  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (35,426) (11,382) 1,378  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.